SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
公司代码SIBN
公司名称SI-BONE Inc
上市日期Oct 17, 2018
CEOFrancis (Laura A)
员工数量349
证券类型Ordinary Share
年结日Oct 17
公司地址471 El Camino Real, Suite 101
城市SANTA CLARA
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编95050
电话14082070700
网址https://si-bone.com/
公司代码SIBN
上市日期Oct 17, 2018
CEOFrancis (Laura A)